TMEM184C
Transmembrane protein 184C
Also known as: FLJ10846, T184C_HUMAN, TMEM34
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NVA4
- Gene
- TMEM184C
- Ensembl
- ENSG00000164168
- Chromosome
- 4
- Canonical length
- 438 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
Predicted to enable transmembrane transporter activity. Predicted to be involved in transmembrane transport. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
438 residues, UniProt reviewed canonical sequence.
>Q9NVA4|TMEM184C
1 MPCTCTWRNW RQWIRPLVAV IYLVSIVVAV PLCVWELQKL EVGIHTKAWF IAGIFLLLTI
61 PISLWVILQH LVHYTQPELQ KPIIRILWMV PIYSLDSWIA LKYPGIAIYV DTCRECYEAY
121 VIYNFMGFLT NYLTNRYPNL VLILEAKDQQ KHFPPLCCCP PWAMGEVLLF RCKLGVLQYT
181 VVRPFTTIVA LICELLGIYD EGNFSFSNAW TYLVIINNMS QLFAMYCLLL FYKVLKEELS
241 PIQPVGKFLC VKLVVFVSFW QAVVIALLVK VGVISEKHTW EWQTVEAVAT GLQDFIICIE
301 MFLAAIAHHY TFSYKPYVQE AEEGSCFDSF LAMWDVSDIR DDISEQVRHV GRTVRGHPRK
361 KLFPEDQDQN EHTSLLSSSS QDAISIASSM PPSPMGHYQG FGHTVTPQTT PTTAKISDEI
421 LSDTIGEKKE PSDKSVDSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM184C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 124 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 124 nTPM
- thyroid gland: 31 nTPM
- adrenal gland: 20 nTPM
- liver: 19 nTPM
- kidney: 19 nTPM
- placenta: 18 nTPM
Single-cell type
- epicardial cells: 894 nCPM
- innate lymphoid cells: 234 nCPM
- pdcs: 130 nCPM
- thymocytes: 99 nCPM
- cardiomyocytes: 97 nCPM
- early spermatids: 91 nCPM
Immune cell
- basophil: 20 nTPM
- MAIT T-cell: 19 nTPM
- non-classical monocyte: 18 nTPM
- intermediate monocyte: 17 nTPM
- myeloid DC: 16 nTPM
- gdT-cell: 15 nTPM
Brain region
- cerebral cortex: 45 nTPM
- white matter: 35 nTPM
- choroid plexus: 34 nTPM
- hippocampal formation: 34 nTPM
- cerebellum: 33 nTPM
- thalamus: 33 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0.07
- gnomAD missense Z
- 2.57
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM184C as an antibody target. Whether an autoantibody or antibody against TMEM184C could matter depends on whether native TMEM184C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM184C is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM184C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...